Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of an investigational antitumor agent (Japan, Novartis)
jRCT2080223866Phase 1Completed
- Sponsor
- Novartis
- Start
- Apr 2018
01
Overview
Phase 1 trial in Non-hematologic malignancy, sponsored by Novartis. Started Apr 2018; status: completed.
02
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT2080223866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223866.